Cargando…

Correction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7

Detalles Bibliográficos
Autores principales:	Jia, Zhifan, Wang, Kun, Wang, Guangxiu, Zhang, Anling, Pu, Peiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795152/ http://dx.doi.org/10.1371/annotation/9a8447a4-bffe-445f-b323-7e200896aea9

Ejemplares similares

MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7
por: Jia, Zhifan, et al.
Publicado: (2013)

Retraction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7
Publicado: (2020)

miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway
por: Wang, Weihan, et al.
Publicado: (2021)

The emerging role of miR‐19 in glioma
por: Wang, Weihan, et al.
Publicado: (2018)

MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling
por: Sun, Jikui, et al.
Publicado: (2017)

MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma
por: TIAN, YUAN, et al.
Publicado: (2011)

The role of transcriptional coactivator TAZ in gliomas
por: Li, Weijie, et al.
Publicado: (2016)

The Different Role of Notch1 and Notch2 in Astrocytic Gliomas
por: Xu, Peng, et al.
Publicado: (2013)

The role of PKN1 in glioma pathogenesis and the antiglioma effect of raloxifene targeting PKN1
por: Hao, Yubing, et al.
Publicado: (2023)

Improved targeting of miRNA with antisense oligonucleotides
por: Davis, Scott, et al.
Publicado: (2006)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
por: Bajan, Sarah, et al.
Publicado: (2020)

Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
por: Anderson, Brian R., et al.
Publicado: (2020)

An Antisense Oligonucleotide Drug Targeting miR-21 Induces H1650 Apoptosis and Caspase Activation
por: Ge, Jian-Hua, et al.
Publicado: (2019)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Suppression of kinesin expression in cultured hippocampal neurons using antisense oligonucleotides
Publicado: (1992)

Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway
por: Ding, Tao, et al.
Publicado: (2018)

Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells
por: Adamus, Tomasz, et al.
Publicado: (2021)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
por: Hua, Yimin, et al.
Publicado: (2007)

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
por: Alharbi, Arwaf S, et al.
Publicado: (2020)

Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis
por: Luna Velez, Maria V., et al.
Publicado: (2019)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

AOBase: a database for antisense oligonucleotides selection and design
por: Bo, Xiaochen, et al.
Publicado: (2006)

Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
por: Gurlo, Tatyana, et al.
Publicado: (2023)

Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment
por: O’Callaghan, Brennon, et al.
Publicado: (2020)

An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory Enhancement
por: Poplawski, Shane G., et al.
Publicado: (2020)

Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth
por: Kontaki, Haroula, et al.
Publicado: (2021)

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
por: Nishina, Tomoko, et al.
Publicado: (2015)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish
por: Pauli, Andrea, et al.
Publicado: (2015)

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
por: Sardone, Valentina, et al.
Publicado: (2017)

The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases
por: Ulanova, Marina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p7s0vtn9oc9fd9uqu76236nk0h